胎盘生物钟蛋白BHLHE41通过非泛素化依赖的蛋白酶体降解途径调控HIF-1α在子痫前期发病中的机制研究
批准号:
82101785
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
赵焕强
依托单位:
学科分类:
妊娠相关性疾病
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
赵焕强
中文摘要
最新证据提示子痫前期(PE)是一种胎盘生物节律紊乱性疾病,但分子机制不明。申请人前期发现生物钟基因BHLHE41全身性敲除孕鼠出现PE样征状,并伴随胎盘HIF-1α水平升高;分子机制实验提示BHLHE41不影响HIF-1α泛素化修饰。故提出科学假说:胎盘生物钟蛋白BHLHE41通过非泛素化依赖的蛋白酶体降解途径调控HIF-1α表达,参与PE发病过程。本项目拟①采用病例对照研究及分析公共数据库,阐明BHLHE41与子痫前期发病、严重程度及血压昼夜节律的相关性;②利用条件性基因敲除鼠阐明胎盘BHLHE41下调是PE发病及血压节律紊乱的重要因素;③在类器官及细胞水平上阐明BHLHE41对滋养细胞抗/促血管生成因子及自噬水平的影响;④在分子水平上证明BHLHE41通过非泛素化依赖的蛋白酶体降解途径调控HIF-1α。本项目首次从生物节律角度阐释PE发病机制,以期为该病精准诊疗提供新理论和新靶点。
英文摘要
Recent evidence suggests preeclampsia (PE) is a placental disorder of circadian rhythm; however, the molecular mechanism remains unknown. We have found that the pregnant BHLHE41-/- mice showed PE-like symptoms with the increased level of hypoxia inducing factor 1 alpha (HIF-1α) in placentae. Molecular experiments suggested that BHLHE41 did not affect HIF-1α ubiquitination. We hypothesize that placental clock protein BHLHE41 promoting degradation of HIF-1α by a ubiquitin-independent pathway, which is involved in the pathogenesis of PE. This study includes four parts: ① Analysis of the correlation between BHLHE41 and the severity of PE, and circadian rhythm of blood pressure using a case-control study; ② Elucidating that down-regulation of BHLHE41 in placenta is an important mechanism of PE pathogenesis using conditional BHLHE41 knockout mice; ③ Investigating the effects of BHLHE41 on autophagic regulation and placental angiogenic balance of trophoblast at cellular/organoid-level; ④Uncovering the mechanism that BHLHE41 down-regulates HIF-1α in a ubiquitin-independent proteasome manner. To the best of our knowledge, this project was the first to explain the pathogenesis of PE from the perspective of circadian clock, which will provide a new idea for the etiology of preeclampsia.
最新证据表明,子痫前期(PE)是一种胎盘生物节律紊乱性疾病,但其分子机制尚不明确。申请人在之前的研究中发现,全身性敲除生物钟基因BHLHE41的孕鼠出现PE样症状。项目的科学问题是:生物钟基因BHLHE41在子痫前期发病中的作用是什么?研究结果如下:1. 孟德尔随机化分析发现,睡眠障碍引起的生物钟紊乱与子痫前期发病之间存在因果关系;2. 在临床样本中,分析阐明胎盘BHLHE41下调与子痫前期发病的相关性;3. 在动物实验中,条件性敲除胎盘BHLHE41通过抑制氧化磷酸化诱导子痫前期的发病;4. 在类器官或细胞水平上,研究阐明BHLHE41对滋养细胞中抗/促血管生成因子表达及氧化磷酸化的影响。本项目首次从生物节律的角度阐释了PE的发病机制,旨在为该病的精准诊疗提供新的理论依据和治疗靶点。
国内基金
海外基金